Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

100th Surgical Implantation of ZIP ULTRA™ MIS Interspinous Device Performed in Canada


Posted on: 09 Jul 18

CARLSBAD, Calif., July 09, 2018 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (TSXV:ASG) ("Aurora Spine" or the "Company") announced today the 100th surgical implantation of the company's ZIP ULTRA® minimally invasive interspinous device in Canada. These surgeries are part of Aurora Spine's continuing efforts to expand the use of the Company’s ZIP® MIS Fusion System in North America.

The 100th surgery was completed with a ZIP implant provided by Venture Medical, Ltd. and performed at False Creek Healthcare Centre in Vancouver, BC by Navraj Heran, MD, the center’s Chief of Neurosurgery.

"The Aurora Spine ZIP ULTRA MIS fusion system is a very intuitive and easy to use system that allows me to perform a short and safe surgery while avoiding the risk of nerve impact," said Dr. Heran. “The ZIP device is minimally invasive and the implantation is fast and simple via a small incision.”

"We are very excited to continue offering our ZIP MIS products in Canada," said Laszlo Garamszegi, Chief Technology Officer and VP of Engineering of Aurora Spine. “The ZIP family of products is designed to be simple, safe and secure with minimal disruption to patients and we are convinced that ZIP implants will contribute to improved patient outcomes in Canada."

Aurora Spine's patented ZIP ULTRA MIS interspinous fixation implant for spinal fusion consists of the ONE-STEP™ locking mechanism, which eliminates the use of a set screw, articulating spikes and various sizes to accommodate variations in patient anatomy.

“We are passionate about delivering innovative, first-class products like the ZIP spinal implant to the Canadian market,” said Chris Walsh, President and CEO of Venture Medical, Ltd. “The ZIP implant device is proven to be one of the most significant, minimally invasive technology solutions in the Canadian healthcare market.”

About Dr. Heran

Dr. Navraj Heran is a locally raised and practicing neurosurgeon maintaining a very active neurosurgical profile at several hospitals in the Greater Vancouver area including Royal Columbian Hospital, Eagle Ridge Hospital and Lion’s Gate Hospital. He is specialized in minimal access techniques in neurospine, neurosurgery and endovascular neurosurgery.

About False Creek Healthcare Centre

False Creek Healthcare Centre in Vancouver, BC was founded in 1996 and has grown to become one of Canada’s most renowned independent health providers. This state-of-the-art centre is more than just a medical clinic; it offers world-class service to individuals seeking immediate access to high quality medical care in Canada, utilizing the most advanced technology and techniques available.  Learn more about False Creek Healthcare Centre at their website: https://www.centrichealthsurgical.com/location/vancouver

About the ZIP Implant

“The combination of the proven ONE-STEP™ locking mechanism and our minimally invasive design allows patients in Canada to receive a screwless fusion treatment as a pedicle screw alternative,” said Trent Northcutt, President and CEO of Aurora Spine.

About Aurora Spine

Aurora Spine is an early stage company focused on bringing new solutions to the spinal implant market through a series of screwless, innovative, minimally invasive, regenerative spinal implant technologies. Aurora Spine continues to position itself at the forefront of spinal surgery procedures, focusing on minimally invasive spine surgery technologies. Aurora Spine is changing spine surgery by focusing on disruptive technologies following the Company's commitment to - Simplifying the Complex.

Forward-Looking Statements

This news release contains forward-looking information that involves substantial known and unknown risks and uncertainties, most of which are beyond the control of Aurora Spine, including, without limitation, those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Information" in Aurora Spine's final prospectus (collectively, "forward-looking information"). Forward-looking information in this news release includes information concerning the proposed use and success of the company’s products in surgical procedures. Aurora Spine cautions investors of Aurora Spine's securities about important factors that could cause Aurora Spine's actual results to differ materially from those projected in any forward-looking statements included in this news release. Any statements that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-looking and may involve estimates, assumptions and uncertainties which could cause actual results or outcomes to differ unilaterally from those expressed in such forward-looking statements. No assurance can be given that the expectations set out herein will prove to be correct and, accordingly, prospective investors should not place undue reliance on these forward looking statements. These statements speak only as of the date of this press release and Aurora Spine does not assume any obligation to update or revise them to reflect new events or circumstances.

CONTACT INFORMATION

Aurora Spine Corporation

Trent Northcutt
President and Chief Executive Officer
(760) 424-2004

Sarina Mason
Chief Financial Officer
(760) 424-2004

www.aurora-spine.com

GlobeNewswire
globenewswire.com

Last updated on: 10/07/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.